SCHEMBL5116768

SCHEMBL5116768

CC(=O)Nc1cc(Cl)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 2/20 0.39
ABL1 P00519 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RIN1 Q13671 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
BRD4 O60885 5/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR139 Q6DWJ6 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722484 0.94 ALDH1A1 (0.36) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL5107711 0.91 ALDH1A1 (0.39) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL5104790 0.91 BRD4 (0.36) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL5119779 0.90 MEN1 (0.40) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL5119943 0.90 ALDH1A1 (0.38) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL4931803 0.90 ALDH1A1 (0.38) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL4927388 0.89 GPR139 (0.38) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL4947897 0.88 KMT2A (0.39) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL5117906 0.87 HPGD (0.45) HPGDALDH1A1MEN1KMT2ARAB9A
SCHEMBL4930661 0.86 KMT2A (0.38) HPGDALDH1A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA HPGD 3449/4885ALDH1A1 2530/4885MEN1 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.